argus

Shukra Pharmaceuticals Limited

NSE: SHUKRAPHARINE551C010442,286 Cr

Timeline

Time (IST)TypeMEventSrc
03 Sept, 08:12 pmother1Shukra Pharmaceuticals Limited provides general updates to the exchange with no specific economic event or financial figures disclosed.nse
03 Sept, 12:20 pmother1Shukra Pharmaceuticals Limited provides general updates to the stock exchange.nse
02 Sept, 06:53 pmresults2Shukra Pharmaceuticals reported quarterly results for the period ending September 2026, with revenue of 56.7 Cr and profit of 22.1 Cr.nse
22 Aug, 02:50 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for AGM And Change Of Namebse
22 Aug, 02:46 pmShukra Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2026.nse
17 Aug, 07:14 pmShukra Pharmaceuticals Limited has informed the Exchange about General Updatesnse
17 Aug, 07:08 pmShukra Pharmaceuticals Ltd - 524632 - Media Releasebse
17 Aug, 02:21 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for AGMbse
14 Aug, 03:29 pmShukra Pharmaceuticals Ltd - 524632 - Reg 30 NSE Listing Donebse
14 Aug, 03:21 pmShukra Pharmaceuticals Limited has informed the Exchange about General Updatesnse
14 Aug, 03:18 pmShukra Pharmaceuticals Ltd - 524632 - Reg 30 Change Of Name In Objectbse
14 Aug, 03:12 pmShukra Pharmaceuticals Limited has informed the Exchange about General Updatesnse
14 Aug, 12:14 pmShukra Pharmaceuticals Limited has informed the Exchange about General Updatesnse
14 Aug, 12:09 pmShukra Pharmaceuticals Limited has informed the Exchange about General Updatesnse
14 Aug, 12:02 pmShukra Pharmaceuticals Ltd - 524632 - Reg 30bse
14 Aug, 11:59 amShukra Pharmaceuticals Ltd - 524632 - Media Releasebse
12 Aug, 02:46 pmShukra Pharmaceuticals Ltd - 524632 - Quarterly Results June 30, 2026bse
12 Aug, 02:39 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Quartely Results June 30, 2026bse
06 Aug, 06:10 pmShukra Pharmaceuticals Ltd - 524632 - Update on board meetingbse
30 Jul, 07:19 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Quarterly Resultsbse
14 Jul, 07:36 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday, July 14, 2026 For Confirmation Of Receipt Of The Differential Upfront Consideration From The Allottees Pursuant To Regulation 170(2) Of The SEBI (ICDR) Regulations, 2018bse
15 Jun, 07:15 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Appointment And Resignation Of Company Secretary & Compliance Officerbse
10 Jun, 06:58 pmprocedural1The board meeting outcome disclosure was filed for the meeting held on June 10, 2026, but the substantive resolution details are not provided in the text.bse
05 Jun, 07:07 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Ratification Of Approval For Member''s Resolution Passed In The Extra-Ordinary General Meeting Dated 01St November, 2025bse
07 May, 11:13 pmShukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Allotmentbse
07 May, 10:51 pmShukra Pharmaceuticals Ltd - 524632 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
07 May, 10:43 pmShukra Pharmaceuticals Ltd - 524632 - Corporate Action-Board approves Dividendbse
07 May, 10:38 pmShukra Pharmaceuticals Ltd - 524632 - Regulation 32 For Starement Of Deviationbse
07 May, 10:33 pmShukra Pharmaceuticals Ltd - 524632 - Results For The Financial Year Ended March 31, 2026bse
07 May, 10:22 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome For The Board Meeting Dated 07.05.2026 For The Audited Financial Results For The Quarter And Year Ended March, 2026bse
29 Apr, 05:43 pmShukra Pharmaceuticals Ltd - 524632 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure Abse
29 Apr, 03:48 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March, 2026 Along With The Auditor''s Reportbse
16 Mar, 01:33 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Independent Directors Meetingbse
06 Mar, 04:44 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Independent Directors Meetingbse
05 Feb, 02:13 pmShukra Pharmaceuticals Ltd - 524632 - Newspaper Publication Of Standalone And Consolidated Un-Audited Financial Results For Quarter And Nine Month Ended 31St December 2025bse
04 Feb, 04:27 pmShukra Pharmaceuticals Ltd - 524632 - Unaudited Financial Results For The Quarter Ended December 2025bse
04 Feb, 04:07 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday, February 04, 2026bse
30 Jan, 07:00 pmShukra Pharmaceuticals Ltd - 524632 - Update on board meetingbse
30 Jan, 02:58 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Unaudited Financial Result For The Third Quarter Ended On 31 December, 2025 Along With The Auditor''s Limited Review Report.bse
28 Jan, 08:11 pmShukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Allotmentbse
28 Jan, 08:08 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Todaybse
05 Jan, 03:13 pmShukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreementsbse
30 Dec, 07:20 pmShukra Pharmaceuticals Ltd - 524632 - Reconstitution Of Committees Of The Company.bse
30 Dec, 07:19 pmShukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Change in Managementbse
30 Dec, 07:17 pmShukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse
30 Dec, 07:16 pmShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On December 30, 2025.bse
22 Dec, 12:20 pmShukra Pharmaceuticals Ltd - 524632 - Intimation For Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations, Working In The Government Market Of Gujarat For Our Laparoscopic Sets And Accessories.bse
03 Dec, 03:17 pmShukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Orderbse
29 Nov, 07:03 pmShukra Pharmaceuticals Ltd - 524632 - Approval Of Continuation Of Directorship Of Mr. Jitendra Somchand Shah Non-Executive Independent Director Who Has Attained Age Of 75 Years On September 22, 2025 Subject To Approval Of Shareholders.bse
29 Nov, 06:48 pmShukra Pharmaceuticals Ltd - 524632 - Outcome Of The Meeting Of The Board Of Directors Held On Saturday, November 29, 2025bse